You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (78)

Journals (0)

1-10 of 78 results for long-acting muscarinic antagonist

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases

Free access

Review article

First published 2014-3

Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases

Khuder Alagha, Alain Palot, Tunde Sofalvi [...]

Sage Open Chronic Disease

Select article: NVA237,a long-acting muscarinic antagonist,as an emerging therapy for chronic obstructive pulmonary disease

Free access

Review article

First published 2011-6

NVA237,a long-acting muscarinic antagonist,as an emerging therapy for chronic obstructive pulmonary disease

Claus Vogelmeier, Donald Banerji

Therapeutic Advances in Respiratory Disease

Select article: The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis

Open access

Research article

First published 2023-03

The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis

Kazuya Tanimura, Susumu Sato, Yukio Fujita [...]

Chronic Respiratory Disease

Select article: Long-acting muscarinic antagonist and long-acting β 2 -agonist combination for the treatment of maintenance therapy–naïve patients with chronic obstructive pulmonary disease: a narrative review

Open access

Review article

First published 2024

Long-acting muscarinic antagonist and long-acting β 2 -agonist combination for the treatment of maintenance therapy–naïve patients with chronic obstructive pulmonary disease: a narrative review

Roland Buhl, Marc Miravitlles, Antonio Anzueto [...]

Therapeutic Advances in Respiratory Disease

Select article: Role of Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist Therapy in Chronic Obstructive Pulmonary Disease

Retricted access

Review article

First published 2017-8

Role of Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist Therapy in Chronic Obstructive Pulmonary Disease

Sarah E. Petite

Annals of Pharmacotherapy

Select article: Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β 2 -agonist fixed-dose combinations in COPD

Open access

Research article

First published 2019

Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β 2 -agonist fixed-dose combinations in COPD

Mohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins [...]

Therapeutic Advances in Respiratory Disease

Select article: Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease

Free access

Review article

First published 2015-6

Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease

Paul W. Jones

Therapeutic Advances in Respiratory Disease

Select article: Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease

Open access

Review article

First published 2019-3

Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease

Roy A. Pleasants

Annals of Pharmacotherapy

Select article: Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis

Free access

Research article

First published 2016-4

Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis

Max Schlueter, N Gonzalez-Rojas, Michael Baldwin [...]

Therapeutic Advances in Respiratory Disease

Select article: Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression

Free access

Research article

First published 2015-2

Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression

Yuji Oba, Nazir A. Lone

Therapeutic Advances in Respiratory Disease

1
2
3
•••
8
10 / page

Article type

Publication date

Subjects

Access